Sign In
Get Clay Free →

Suggestions

    Paul Coplan

    VP and Head, Medical Device Epidemiology & Real World Data Sciences at Johnson and Johnson

    Paul Coplan is the Vice President and Global Head of Medical Device Epidemiology at Johnson & Johnson MedTech, leading a team focused on epidemiology and real-world data sciences for medical devices.13 He has extensive experience in both pharmaceutical and medical device industries, with a career spanning over 28 years in analytic research in public health.3

    Coplan holds multiple advanced degrees, including a BS Honors in Biochemistry and Physiology, a Master's in Public Health and Nutrition, a Doctor of Science in Epidemiology and Biostatistics from Harvard School of Public Health, and an MBA from Wharton Business School at the University of Pennsylvania.1

    Throughout his career, Coplan has been a pioneer in using epidemiology and real-world evidence to develop new vaccines, medicines, and medical technologies, as well as assess their postmarket safety and effectiveness.1 He has contributed to the development of several widely used vaccines and medicines, including Johnson & Johnson's Covid-19 vaccine.1

    In addition to his role at Johnson & Johnson, Coplan has been an adjunct professor teaching Epidemiology at the University of Pennsylvania Perelman School of Medicine for over 21 years.13 He has authored over 90 peer-reviewed scientific articles and presented at 500 international medical conferences.1

    Coplan has led initiatives for collaboration between companies, regulators, and academics in various areas, including creating benefit-risk frameworks for medical product evaluations and assessing the safety of various medical products.1 He is also a member of several important committees in the medical device industry, including the National Evaluation System for Health Technology's Active Surveillance Workgroup.1

    Recently, Coplan has been spearheading efforts to expand the use of real-world evidence in the medical device industry. Under his leadership, Johnson & Johnson became the first medtech company to receive an FDA-approved label extension using real-world evidence.2

    Highlights

    Sep 3 · mystrategist.com
    J&J's Paul Coplan Maps a New Path - MyStrategist
    Aug 13 · mystrategist.com
    Pioneering the Use of Real-World Evidence: An Interview With J&J's ...

    Related Questions

    What are some of Paul Coplan's most notable achievements at Johnson & Johnson?
    How has Paul Coplan's work impacted the development of vaccines and medical devices?
    What role did Paul Coplan play in the development of Johnson & Johnson's COVID-19 vaccine?
    Can you provide examples of Paul Coplan's contributions to real-world evidence in medtech?
    How has Paul Coplan's background in both pharma and medtech influenced his approach at Johnson & Johnson?
    Paul Coplan
    Add to my network

    Location

    New Brunswick, New Jersey, United States